Furthermore, recent studies discussed potential prognostic utility of mutations in alpha-thalassemia/mental retardation X-linked chromatin remodeler (ATRX) and death-domain-associated protein (DAXX) genes in metastatic disease in pancreatic NETs. This evidence concerns the gene DAXX and Alpha-thalassemia.